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Abstract
Background: Non-surgical periodontal therapy (NSPT) known as gold standard treatment in managing
periodontitis. The aim of this study was to investigate the response of NSPT in periodontitis subjects who were
obese. Clinical parameters of periodontitis, changes in serum resistin and periodontal pathogens in subgingival
plaque were compared before and after NSPT in periodontitis subjects who were obese and with normal weight.
Methods: A total of 48 periodontitis subjects (obese, n = 18; normal weight, n = 30) were recruited (hereafter will
be referred as participants) to participate into a prospective, before and after clinical trial. Obesity status is defined
by body mass index (BMI) criteria (obese: ≥30 kg/ m2; normal weight < 25 kg/m2). Visible Plaque Index (VPI), Gingival
Bleeding Index (GBI), Probing Pocket Depth (PPD) and Clinical Attachment Loss (CAL) were recorded; and serum
and plaque were collected at baseline and following 12 weeks post-NSPT. Serum resistin level was analyzed using
enzyme-linked immune-sorbant assay (ELISA), while detection of periodontal pathogens in dental plaque were
carried out using real time PCR (qPCR).
Results: Following NSPT, means VPI and GBI showed significant improvement between obese and normal weight
groups (p < 0.05), but no difference in means PPD and CAL was observed between groups. Obesity remained as a
predictor for VPI and GBI after adjusting for smoking habit. No significant difference was observed in serum resistin
level and mean counts for P. gingivalis, T. forsythia, and P. intermedia between obese and normal weight groups
following NSPT.
Conclusions: Regardless of obesity status, NSPT has a significant impact on VPI and GBI in periodontitis subjects.
However, the impact of NSPT towards serum resistin and periodontal pathogens was non-significant in those with
periodontitis.
Trial registration: This study followed the Consolidation Standards of Reporting Trials Statement and
retrospectively registered on 26/11/2015 at clinicaltrials.gov (No. NCT02618486).
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Background
Periodontal therapy is aimed to provide functional denti-
tion and comfort for patients [1] with periodontitis.
Non–surgical periodontal therapy (NSPT) focuses on
elimination of bacterial plaque on the root surface by
means of scaling and root surface debridement and pre-
paring the root surface for healing. NSPT has been
shown to provide improvement in clinical parameters
namely, Visible Plaque Index (VPI), Gingival Bleeding
Index (GBI), Probing Pocket Depth (PPD), Clinical At-
tachment Level (CAL), as well as reduction inflamma-
tion and in periodontal pathogens. NSPT was shown to
induce a shift from a pre-dominant Gram negative to a
Gram positive subgingival microbiota in the general
population [2] and to significantly reduce total bacteria
counts and positive sites of P. gingivalis and T. forsythia
[3, 4]. NSPT is also expected to reduce the serum resis-
tin level, which otherwise is present in higher amount in
case of periodontal inflammation with periodontitis pa-
tients as compared to healthy individuals [5].
The outcome of the NSPT might vary depending on the
severity of the disease as well as the other health complica-
tions of the patients such as obesity [6, 7]. Previous research
showed that mean serum resistin was higher in obese sub-
jects with periodontitis followed by non-obese periodontitis
and non-obese healthy [8]. Following 2months post-NSPT,
greater reduction in resistin was observed in normal weight
with periodontitis than obese periodontitis subjects [9]. In
contrast, previous studies which compared obese and non-
obese subjects with periodontitis following NSPT showed
no significant difference in terms of serum levels of resistin
at baseline and 3months post-NSPT [5, 10]. Similarly, obes-
ity condition could enhance the risk of patients to exhibit
periodontitis by having high numbers of pathogenic subgin-
gival species. Previous studies demonstrated that mean
counts of P. gingivalis and T. forsythia were higher in obese
with periodontitis [11, 12].
Resistin is a 12.5 kDA cysteine-rich secretory protein
with mature sequence consists of 108 amino acids. Resis-
tin has been expressed in macrophages, neutrophils and
lymphocytes, and play various regulatory roles in bio-
logical processes including inflammation [13]. The role of
resistin in the inflammatory pathway has been suggested
through a nuclear factor NF-κB pathway [14]. Systematic
and meta-analysis study reported high level of serum
resistin observed in periodontitis patients as compared to
healthy individuals [15]. This could be explained by the in-
creased local pro-inflammatory cytokine levels in patients
with periodontal inflammation, which is also associated
with a state of elevated localized inflammatory burden. On
the same note, obese subjects also showed elevated levels
of serum inflammatory biomarkers (secreted from adipo-
cytes), which modulate inflammatory responses indicating
its possible inflammatory role in periodontitis.
The lack of evidence in this area and conflicting out-
comes from previous studies warrant further investiga-
tions. More specifically, studies on the potential
outcome of NSPT on the periodontal parameters, serum
resistin level, and periodontal pathogens counts in peri-
odontitis with obesity remains largely scanty. Thus, it re-
mains unclear whether NSPT has a significant impact
on these obese patients and normal weight patients, with
periodontitis. Therefore, this study was aimed to evalu-
ate the impact of NSPT on clinical parameters, serum
resistin level and periodontal pathogen count in peri-
odontitis patients with obesity and with normal weight.
Methods
Experimental design and ethics approval
This was a prospective study, before and after clinical
trials, conducted at the Faculty of Dentistry, University
of Malaya between March 2013 and October 2015. Eth-
ical approval was obtained from the Medical Ethics
Committee Faculty of Dentistry, University of Malaya
(DF PE1501/0085(L)).
Participants
The subjects were recruited from those who came for
periodontal treatment at the Faculty of Dentistry, Uni-
versity of Malaya. Case definition for periodontitis by
Eke et al. (2012) was used [16]. The inclusion criteria: (i)
BMI for obese > 30.0 kg/m2 and normal weight < 25.0
kg/m2 with loosened clothing and no shoes [17] (ii)
minimum number of teeth 12 (iii) age > 30 years. The
exclusion criteria: (i) history of periodontal treatment in
last six months, (ii) on medication namely antibiotics
and topical/systemic steroid treatment in last four
months, (iii) current or planning for pregnancy during
the intervention period, (iv) lactating mothers, (iv) men-
tally handicapped, (v) history of valve replacement and
rheumatic heart disease which require antibiotic cover-
age. Self-reported questionnaire was used to obtain in-
formation on sociodemographic, education status,
medical history and habits. Radiograph was taken on
case to case basis.
Sample size calculation
The sample size calculation was determined based on
detectable mean difference of 0.5 mm in CAL between 2
groups [18], a standard error of 5% (p = 0.05) and a
power of 90% (0.9). The estimated sample size was 27
participants for each test and control groups. Due to an-
ticipated 10% for dropouts which had been concluded
from previous studies, thus a total of 30 participants per
group were required. G*Power software version 3.1 was
used [19] and T-test for independent means in an ana-
lysis statistical program was selected.
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Clinical assessment
The intra-examiner calibration involved an examiner (AH).
The reproducibility of the clinical measurement was per-
formed on 84 sites evaluated for PPD and CAL. The intra-
examiner agreement (κ values) for PPD and CAL were 0.73
and 0.87 respectively. For inter-examiner calibration, 4 ex-
aminers were calibrated against an experienced periodontist
on 168 sites for PPD and CAL. The inter-examiner agree-
ment (κ values) for PPD and CAL were 0.79 and 0.87 re-
spectively. Periodontal measurements and treatment was
performed by the same examiner (AH). Full mouth Visible
Plaque Index (VPI) [20], Gingival Bleeding Index [20], (VPI
and GBI; absence or presence), probing pocket depth
(PPD) and clinical attachment level (CAL) were assessed at
six sites per tooth (mesiobuccal, midbuccal, distobuccal,
mesiopalatal, midpalatal and distopalatal). For both groups,
the measurements were carried out at baseline and at 12
weeks post-NSPT.
Non-surgical periodontal treatment (NSPT)
All patients were given (i) standardized oral hygiene in-
struction namely tooth brushing with modified Bass tech-
nique and flossing, (ii) full mouth scaling; and (iii) root
surface debridement at sites with PPD ≥ 5mm [21] using
an ultrasonic scaler Sirona C8 03653 (Dentsply Sirona,
New York, USA) and Graceys curettes (Hu Friedy, Chicago,
USA). The treated periodontal pockets were irrigated with
0.12% chlorhexidine gluconate (Oradex®). Patients were ad-
vised to rinse their mouth three times daily for 14 days
using 15ml of 0.12% chlorhexidine gluconate mouthwash
[22]. The primary outcomes of the study were serum resis-
tin levels and periodontal pathogens counts.
Quantification of resistin
Levels of resistin was measured in serum from each partici-
pant at baseline (prior to NSPT) and at 12 weeks after
NSPT using ELISA kits according to instructions of the
manufacturer (Quantikine HS, R&D System Europe Ltd.,
UK). Briefly, 5mL of venous blood from each participant
was centrifuged at 1000 g for 15min and stored in Eppen-
dorf tubes at − 80 °C until further analysis. Thawed serum
samples were diluted 25× using the diluent provided in the
kit for ELISA. Purified resistin (100 ng/mL) was used as
standard while the assay diluent was used as the blank. In a
well of a 96 wells micro-titer plate, 100 μL of assay diluent
with either 100 μL of diluted standard or diluted were
added. Following 2-h incubation at room temperature, the
wells were aspirated and washed for 3–4 times using the
wash buffer. 200 μL of human conjugate (monoclonal anti-
body against resistin conjugated to horseradish peroxidase)
was added to each well and incubated at room temperature
for another 2-h. The washing steps were repeated. 200 μL
of substrate solution (stabilized hydrogen peroxide and tet-
ramethylbenzidine) was added to each well and incubated
in dark for 30min at room temperature. 50 μL of stop solu-
tion was added to the wells to stop the reaction. The ab-
sorbance was recorded at a wavelength of 450 nm. The
concentration serum resistin level (ng/mL) was determined
using the standard curve that had been running using the
positive control. The minimum detection limits for resistin
was 0.026 ng/mL as stated in the ELISA kit. The assay pro-
cedure was performed in duplicate.
Detection and quantification of periodontal
microorganisms using qPCR
Subgingival plaque samples were collected from the dee-
pest periodontal sites using sterile curette from each
participant at baseline (prior to NSPT) and at 12 weeks
after NSPT. Prior to sampling, the tooth was isolated
with a cotton roll and supragingival plaque was removed
using cotton pellets. Following this, the subgingival
plaque was taken using sterile Gracey’s curette by scrap-
ping from the base of the pockets up to the gingival
margin of at least four sites with the deepest probing
depths which showed bleeding on probing [23]. The
samples were placed in 1.5 ml Eppendorf tubes contain-
ing phosphate buffered saline (PBS) and stored at −
80 °C until assayed. The plaque samples were centrifuged
at 13, 000 rpm for 5min and the supernatant removed.
Bacterial DNA was extracted using automated DNA ex-
traction device (QIAcube, Qiagen Biotechnology, Kuala
Lumpur, Malaysia) according to manufacturer’s instruc-
tion. The concentration and purity of all samples were
measured with a spectrophotometer (NanoDrop 2000,
Thermo Scientific, Wilmington, DE, USA).
A qPCR assay using singleplex TaqMan gene expression
assays (Applied Biosystems®) was used for the detection and
quantification of single-copy gene of W83 gene for P. gingi-
valis, ATCC 43037 gene for T. forsythia, and ATCC 25611
gene for P. intermedia. A 10-fold dilution series of genomic
DNA at the concentrations 100 ng/ μL was used to create
the standard curve as reference each periodontal pathogen.
Each gene was duplicated for standard curve assays with
negative control. The final graph with curve of correlation
coefficient (R2) ≤ 0.99 and the efficiency ranges between 90
and 100% was used as the standard curve. Briefly, the reac-
tion mixture contained 10 μL of 2× TaqMan Fast Advanced
Master Mix (Applied Biosystems), 1 μL of 20 × gene expres-
sion assay, 7 μL nuclease-free water and 2 μL of template
DNA from the plaque sample [23]. The assay was per-
formed in a MicroAmp™ optical 96-well reaction plate (Ap-
plied Biosystems®). The quantification was performed using
a thermal cycler (7500 Fast RT–PCR System, Applied Bio-
systems®) with a pre-defined programme; stages of enzyme
activation at 95 °C for 20 s, 40 cycles of denaturation (at
95 °C for 3 s per cycle), annealing and extension phases (at
60 °C for 30 s each phase) [24].
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Statistical analysis
Data entry and statistical analysis were carried out
using Statistical Package for the Social Sciences
(SPSS), version 18.0 (SPSS Inc. Chicago, IL, USA).
The data was tested for normality of distribution
using Shapiro–Wilk test before testing for the hy-
pothesis analysis. P–value of less than 0.05 was set as
the statistically significant value. Independent T–test
and Chi square test were used to analyze the socio-
demographic profile of the participants. Comparison
means between group at baseline and 12 weeks post
NSPT were analyzed using Independent T-test or
Mann-Whitney test. Repeated measures ANOVA was
used to compare the changes (from baseline to 12
weeks post NSPT) in means of clinical parameters,
serum resistin levels and periodontal pathogens within
group and between groups. The significant level was
determined when 95% CI showed no overlapping
values. Regression analysis was employed to identify
explanatory variables for obesity status, controlling
the effects of other possible covariates. The flow of
the study is shown in Fig. 1.
Results
Socio-demographic profile of the participants
Initially, there were 24 obese and 30 normal weight par-
ticipants recruited in the study. However, 6 participants
from obese group were dropout (outlier data), thus their
data was excluded (Fig. 1). Only 48 participants com-
pleted the study (obese = 18 and normal weight = 30)
(Table 2). In terms of gender, both male and females
were dominant among normal weight group. In respect
to ethnicity, Malays were dominant among the obese
group (Table 1). However, there was no significant dif-
ference in terms of gender and ethnicity between obese
and normal weight groups. It is interesting to note that
out of total 25 female participants 12 (66.7%) were
obese; while out of 23 male participants 6 (33.3%) were
obese (Table 1). Smoking status was significantly domin-
ant among normal weight subjects (p = 0.021).
Measurement of periodontal clinical parameters
Comparison of mean clinical parameters between both
obese and normal weight group with periodontitis at
baseline were showed at Table 2. At baseline, obese
Fig. 1 Study flow diagram
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group showed higher VPI and GBI but lower PPD and
CAL compared with normal weight group. Both the
obese and normal weight groups were shown to have re-
duce percentages of VPI and GBI significantly at 12
weeks post NSPT (p < 0.5) (Table 2). It is important to
note that obese group had significantly higher level
(p < 0.5) of both VPI and GBI at the baseline compared
to those of normal weight group. When comparisons
were made between groups, the obese group experienced
significantly higher mean reduction in VPI (69%) and
GBI (15%) compared to the normal weight group
(p < 0.5) (Table 2). Both obese and normal weight group
Table 1 Socio-demographic profile of the participants
Properties Obese (N = 18) Normal weight (N = 30) p - value
Age (years) [Mean(± SE)] 44.7 (2.4) 47.2 (1.9) 0.405a
BMI [Mean(± SE)] 33.3 (0.9) 23.8 (0.5) 0.000a*
N (%)
Gender
Male 6 (33.3) 17 (56.7) 0.117b
Female 12 (66.7) 13 (43.3)
Ethnicity
Malay 13 (72.2) 12 (40.0) 0.067b
Chinese 1 (5.6) 8 (26.7)
Indian 4 (22.2) 10 (33.3)
Smoking habit
Smoker 3 (16.7) 16 (53.3) 0.021b*
Non-smoker 14 (77.7) 11 (36.7)
Former smoker 1 (5.6) 3 (10.0)
Education level
Tertiary 6 (33.3) 6 (20.0) 0.587b
Secondary 7 (38.9) 14 (46.7)
Primary 5 (27.8) 10 (33.3)
Disease status
Diabetic 3 (16.7) 1 (3.3) 0.106b
Non-diabetic 15 (83.3) 29 (96.7)
aIndependent T-test; bChi-square test; *Significant p-value < 0.05, Primary education level (Primary school), Secondary education level (Secondary school), Tertiary
education level (College or university)
Table 2 Comparison of mean periodontal clinical parameters at baseline and 12 weeks following NSPT
Variables/Groups Baseline 12 weeks after NSPT Mean Reduction after NSPT
VPI (%)
Obese 83.1 (72.3, 93.8) 13.8 (6.5, 21.0)* 69.3 (55.1, 83.4)#
Normal weight 45.5 (38.0, 53.0) 30.5 (24.1, 37.0)* 15.0 (9.2, 20.7)
GBI (%)
Obese 79.1 (68.7, 89.6) 20.3 (12.5, 28.2)* 58.8 (45.6, 72.0)#
Normal weight 40.7 (35.5, 46.0) 25.9 (20.5, 31.2)* 14.9 (9.0, 20.7)
PPD (mm)
Obese 2.4 (2.3, 2.6) 2.1 (1.9, 2.2)* 0.4 (0.2, 0.6)
Normal weight 3.0 (2.7, 3.2) 2.3 (2.1, 2.5)* 0.6 (0.5, 0.8)
CAL (mm)
Obese 3.1 (2.8, 3.5) 2.7 (2.4, 3.0) 0.5 (0.3, 0.7)
Normal weight 3.7 (3.3, 4.1) 3.1 (2.7, 3.5) 0.6 (0.4, 0.7)
*Significant difference within group, #Significant difference between group; mean differences were analyzed at 95% CI (/)
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showed significant reduction of mean PPD following 12
weeks NSPT. However, no mean changes different was
reported when comparison were made between groups.
Further analysis was carried out using multiple regres-
sions (Table 3) as summarized to find out whether obes-
ity status remains the predictor for mean changes in VPI
and GBI. After adjusting for smoking habit, obesity sta-
tus was found significant as a predictor for clinical pa-
rameters of VPI and GBI with p < 0.05. Therefore, obese
subjects would have 54.3 and 43.9% times higher mean
change of VPI and GBI respectively compared to normal
weight when anthropometric properties were similar.
Serum Resistin and periodontal pathogens
The difference between means of serum resistin level at
baseline and 12 weeks after NSPT of either obese or normal
weight group were not statistically significant (Table 4). No
significant changes were found for mean count for P. gingi-
valis (1.7 × 106 copy cells) and T. forsythia (0.6 × 106 copy
cells) at baseline and at 12 weeks post-NSPT in the obese
group (Table 5). However, the mean count of P. intermedia
had decreased [95% CI (0.7, 1.3; 0.4, 0.9)] to almost half
after 12 weeks post NSPT. Mean counts for P. gingivalis, T.
forsythia, and P. intermedia were reduced at 12 weeks post
NSPT in the normal weight group.
Discussion
Periodontitis is a chronic inflammatory response that causes
gingival inflammation and destruction of hard tissues [25];
with 30 to 35% prevalence in the general population world-
wide [26]. Interestingly, the prevalence of periodontitis
among obese populations worldwide has been reported be-
tween 47 to 74% [16, 27, 28]. Clinical conditions of peri-
odontitis might aggravate in patients with other health
complication such as obesity [29]. A positive but weak asso-
ciation between obesity and periodontitis has been reported
[30], with unclear underlying biological mechanisms.
The present study reported no significant difference in
mean serum resistin levels between baseline and 12
weeks after NSPT in both obese and normal weight
groups. The current study findings contradicted other
short-term studies, with a gap of 10–12 weeks to meas-
ure serum resistin following NSPT [31, 32]. Suresh and
co-workers (2018) reported greater reduction in resistin
which was observed in normal weight periodontitis than
obese periodontitis at 8 weeks post-NSPT [9]. Even
though short-term studies can demonstrate improve-
ments of clinical parameters; however, it is not the same
with serum level of cytokines and resistin. This notion is
supported by Ide et al. (2003), who reported that short
term study of 12 week duration could be insufficient to
establish any biochemical changes following NSPT [32].
Thus, a study with a longer duration is recommended to
observe meaningful changes in biochemical parameters.
Tonetti and colleagues (2007) showed that systemic bio-
markers were reduced at 6 months following NSPT [33].
Although these findings were observed at day 1 follow-
ing NSPT; the levels of systemic biomarkers continued
to be more regular after 6 months. D’Aiuto et al. (2005)
in a systematic review suggested that NSPT could trigger
a short term inflammatory response which was followed
by a consistent progressive reduction in systemic inflam-
mation and an improvement in endothelial function
[34]. The obese individuals showed exaggerated inflam-
matory response [35]. However, a single-round of inten-
sive NSPT could have triggered a short-term acute
inflammatory response, resembling acute changes in the
oxidative stress following NSPT [34]. A significant in-
crease in diacron reactive oxygen metabolites (D-ROM)
after NSPT has been reported, with a positive linear cor-
relation between D-ROM levels and systemic inflamma-
tion biomarkers. The acute inflammatory response may
have been triggered by the inevitable periodontal tissue
damage during the procedure. Thus, the acute inflam-
matory findings in relation to oxidative stress could be
explained by the increase in serum resistin in the obese
group following NSPT in the present study.
In the current study, there were non-significant changes
in mean count of P. gingivalis, T. forsythia and P. inter-
media following NSPT in both groups (Table 5). It is to be
noted that there is no report on the changes of periodontal
pathogens count before and after NSPT in periodontitis
with obesity. Previous studies showed that mean count of
P. gingivalis, T. forsythia and P. intermedia could be re-
duced by 7–45% [36, 37] at 12 weeks post-NSPT in CP.
However, the reductions of the similar bacterial flora were
ranged between 18 to 99% after NSPT in periodontitis with
diabetes [38, 39]. The findings from these studies were
Table 4 Comparisons of serum resistin within and between
groups
Resistin (ng/mL)/
Group
Time Mean
Change (95%
CI)
Baseline 12 weeks
Mean (95% CI) Mean (95% CI)
Resistin (ng/mL)
Obese 14.7 (10.8, 18.5) 17.6 (12.4, 22.7) 2.9 (− 3.4, 9.3)
Normal weight 6.9 (4.3, 9.6) 9.5 (6.9, 12.0) 2.5 (0.9, 4.1)
Repeated measures ANOVA
Table 3 Multiple regression clinical parameters with subjects’
characteristic
Variables Model B t p - value
Mean changes
VPI (%) Obese 54.32 8.60 < 0.001*
GBI (%) Obese 43.9 7.23 < 0.001*
Adjusted smoking habit to predict the changes of mean VPI and GBI
*Significant p–value < 0.05
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consistent with the present study in which NSPT is effect-
ive at reducing periodontal pathogens in normal weight
subjects.
The study design was developed before 2017 Classification
for Periodontal Disease and Peri-implant Disease and Con-
ditions, thus the earlier case definition by Eke et al. (2012)
was used [16]. At baseline, the obese group had almost
double mean values of VPI and GBI, reflective of its inflam-
matory condition (Table 2). This concurs with current un-
derstanding that obese is a chronic inflammatory condition,
which could contribute to an increase in the existing inflam-
matory burden associated with periodontitis [40]. This no-
tion is further supported by Suvan et al., (2014) [41] who
suggested obesity could have triggered greater inflammatory
burden in other co–morbidities including periodontitis. This
could imply that obesity condition may compromise the
healing efficiency in those with periodontitis.
In addition, the obese group had lesser severity of peri-
odontitis (lower means PPD and CAL) compared to normal
weight group (Table 2). This could be explained by the fact
that the normal weight group had significantly higher num-
ber of smokers (Table 1). It is well established that cigarette
smoking remains an independent risk factor for develop-
ment and progression of periodontitis, even after controlling
for variables such as oral hygiene, plaque, calculus, socio-
economic and demographical factors. Smoking has been
associated with increasing host susceptibility towards peri-
odontitis; as well as increasing periodontitis severity, by
influencing the healing potential following treatment by
means of its reduced angiogenesis nature. The risk associ-
ated was estimated with odd ratios of 2.5 to 6.0 [42–44]. It
is worth mentioning that majority of the PPD were mea-
sured as less than 4mm indicating a mild periodontitis
among the participants of the study.
NSPT has been reported as an effective treatment to re-
duce local inflammatory burden [34]. In this study, the
means of VPI, GBI and PPD were significantly reduced after
NSPT. The findings were in line with other previous studies
[18, 45]. It is important to note that, clinical parameters
such as VPI, GBI and PPD are associated with active dis-
eased state. Thus, it was expected that participants in both
groups would have responded to NSPT (as a mean of man-
aging active disease) by means of improvement in means
VPI, GBI and PPD. However, NSPT did not result in signifi-
cant reduction in mean CAL, and that could be explained
by the fact that CAL accumulation is more influenced by
the past disease experience rather than the current peri-
odontitis status. CAL is also an estimate of accumulative
periodontal tissue destruction [46, 47]. The extent of the
disease would depend on how long the investigated popula-
tion has been exposed to the disease.
When compared between groups, the obese group
showed higher mean changes of VPI and GBI compared
to the normal weight group, with statistical significant
differences following NSPT (Table 2). This finding was
contradictory to previous studies which reported reduc-
tion in the mean changes of VPI and GBI, but of no sta-
tistically significant difference [45]. Other study reported
significant difference in mean change of CAL at 3
months following NSPT; however no significant differ-
ence in other parameters was identified [18]. The au-
thors deduced that obesity does not contribute to the
total burden of inflammation and suggested both obese
and non-obese participants may have responded equally
well to NSPT based on the intragroup results [18, 45].
We carried out linear (multiple) regression analysis (Table
3) to find out whether obesity could be a predictor for mean
changes in VPI and GBI. After adjusting for smoking habit,
obesity was found to be a significant predictor for VPI and
GBI (p < 0.05). Obese participants were shown to have 54.3
and 43.9% time higher mean changes of VPI and GBI re-
spectively compared to their normal weight counterpart
with similar anthropometric profile. Clearly, NSPT is effect-
ive in reducing local inflammation in periodontitis obese
and normal weight. However, cigarette smoking might have
compromised the host healing potential resulting in rela-
tively lower mean changes of VPI and GBI in the normal
weight group following NSPT. It is worth to note that the
Table 5 Comparisons mean counts of periodontal pathogens within and between groups
Periodontal pathogens/Groups (× 106 copy cells) Mean count (95% CI) Mean count (95% CI) Mean Change (95% CI)
P. gingivalis
Obese 1.7 (1.5, 2.0) 1.5 (1.3, 1.7) 0.2 (0.1, 0.5)
Normal weight 1.8 (1.5, 2.0) 1.4 (1.1, 1.7) 0.4 (0.1, 0.7)
T. forsythia
Obese 0.6 (0.4, 0.8) 0.7 (0.5, 0.9) 0.1 (− 0.1, 0.3)
Normal weight 0.9 (0.8, 1.0) 0.8 (0.6, 0.9) 0.1 (− 0.1, 0.3)
P. intermedia
Obese 1.0 (0.7, 1.3) 0.6 (0.4, 0.9) 0.3 (0.1, 0.6)
Normal weight 1.1 (0.9, 1.2) 1.1 (1.0, 1.3) 0.1 (− 0.1, 0.3)
Repeated measures ANOVA
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majority of participants (Table 1) in this study were non dia-
betic, which is another risk factor for periodontitis.
Post hoc sample size calculation was carried out using
G*Power software version 3.1 [19]. The calculation was
based on detectable mean difference CAL between 2 groups
obtained from this study. With a standard error of 5% (p=
0.05), it demonstrated the power of 43% (0.43). In view of
medium mean difference CAL (0.71mm) obtained from the
study, the 18 obese and 30 normal weight should be accept-
able. The results were deemed acceptable for the sample
size used.
Limitations in this study include (i) most of the partici-
pant had mild periodontitis and (ii) short time monitoring.
Future study should include involvement of obese with
moderate to severe periodontis participants. Hopefully,
this could be useful to evaluate the potential outcome of
NSPT and bring about conclusive outcomes, especially to
rule out the true effects of obesity and periodontis. At the
same time, further consideration should be given on the
length of the study period with increased frequency of
monitioring the other clinical parameters.
Conclusion
Regardless of obesity status, NSPT has a significant impact
on VPI and GBI in periodontitis subjects. However, the
impact of NSPT towards serum resistin and periodontal
pathogens was non-significant in those with periodontitis.
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